Browse grants

National Institutes of Health · Up to $500K

This NIH (NIDCD) U01 cooperative agreement funds high-risk clinical trials developing in vivo high-resolution imaging technologies for the living human inner ear; a clinical trial is required for this mechanism. Eligible applicants include a broad range of domestic and foreign organizations such as higher-education institutions (including minority-serving institutions), tribal governments, faith-based or community organizations, and U.S. territories. The stated maximum is about $500,000. A multidisciplinary team approach is encouraged; review the RFA for full eligibility details.

National Institutes of Health · Up to $500K

This NIH (NIDCD) R01 award funds development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. A wide range of domestic and foreign organizations may apply, including higher-education institutions (including minority-serving institutions), tribal governments, faith-based or community organizations, and U.S. territories. A clinical trial is optional. The stated maximum is about $500,000, and a multidisciplinary team approach is encouraged; review the RFA for full eligibility details.

National Institutes of Health · Amount varies

This NIH (NIDCD) award funds Clinical Research Center Grants (P50) advancing diagnosis, prevention, and treatment of hearing, balance, smell, taste, voice, speech, or language disorders. Eligible applicants are domestic research-capable organizations, including higher-education institutions, nonprofits, tribal governments, faith-based or community organizations, and U.S. territories; foreign organizations are not eligible to apply, though foreign components may be allowed. A low-risk clinical trial is optional, not required. No dollar range is stated, and applicants should read the NOFO closely and contact NIDCD staff before applying.

National Institutes of Health · Amount varies

This NIH R01 funds research examining the efficacy and clinical effectiveness of digital health technologies for the remote management of type 2 diabetes; a clinical trial is required. Eligible applicants include federal agencies, tribal governments, faith- or community-based organizations, regional organizations, and U.S. territories, in addition to standard research institutions. Foreign organizations and the foreign components of U.S. organizations are not eligible, and foreign components are not allowed. No specific award amount is stated in this record; see the NOFO for full eligibility details.

National Institutes of Health · Amount varies

This NIH (NCI) UH2/UH3 award funds both analytical and clinical validation of molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and applicants should already have assays that work on human samples. Foreign organizations and the foreign components of U.S. organizations are not eligible to apply, though some foreign components are allowed. No specific award amount is stated in this record.

National Institutes of Health · Up to $250K

This NIH (NCI) UH3 award funds the clinical validation of already analytically validated molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response, using specimens from clinical trials or studies. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Applicants must already have an analytically validated assay, which narrows who can realistically apply. Foreign organizations and foreign components of U.S. organizations are not eligible to apply; stated funding is around $250,000.

National Institutes of Health · Amount varies

This NIH (NCI) award funds revision applications to clinically validate biomarker assays that were originally developed through existing NIH-supported research grants, meaning applicants generally need an active or prior NCI-supported assay to revise. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Because it builds on prior NIH funding, eligibility is effectively narrow. No specific award amount is stated in this record.

National Institutes of Health · Up to $500K

This NIH (NIGMS) R25 supports organizations developing educational and skills-training programs for the biomedical research workforce, with activities open to the broader research community and spanning career stages from undergraduates to faculty and staff scientists. Eligible applicants include higher-education institutions, nonprofits, tribal governments, faith- or community-based organizations, and federal agencies; independent clinical trials are not allowed. Foreign organizations and the foreign components of U.S. organizations are not eligible, and foreign components are not allowed. Stated funding is up to about $500,000.

National Institutes of Health · Up to $300K

This NIH (CounterACT) R01 funds basic research on how chemical warfare agents, toxic industrial chemicals, and pesticides affect the nervous system, aimed at understanding toxicity mechanisms and identifying therapeutic targets. Eligible applicants include higher-education institutions, nonprofits, tribal governments, faith- or community-based organizations, and federal agencies; clinical trials are not allowed. Foreign (non-U.S.) organizations and the foreign components of U.S. organizations are not eligible to apply. The award appears to be roughly $300,000 in stated funding.

National Institutes of Health · Amount varies

This NIH X01 opportunity provides access to biospecimens (urine, plasma, serum, genomic DNA) and related data from the Population Assessment of Tobacco and Health (PATH) Study rather than direct research funding. It is aimed at investigators at universities, research institutions, and similar eligible organizations, including various minority-serving institutions and tribal entities. Foreign (non-U.S.) organizations and foreign components are not eligible. No award amounts are listed; this is a resource-access mechanism for researchers, not a general grant for nonprofits, businesses, or individuals.

National Institutes of Health · Amount varies

This NIH R61 grant supports exploratory clinical trials in arthritis, musculoskeletal, and skin diseases, and a clinical trial is required. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions and tribal entities. Foreign (non-U.S.) organizations are not eligible to apply, though defined foreign components are allowed. No specific award amounts are listed, and eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly.

National Institutes of Health · Amount varies

This NIH R01 grant funds clinical observational studies in musculoskeletal, rheumatic, and skin diseases. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions and tribal entities. Foreign (non-U.S.) organizations are not eligible to apply, though defined foreign components are allowed; clinical trials are not permitted under this opportunity. No specific award amounts are listed, and eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly.

National Institutes of Health · Amount varies

This NIH R01 grant supports development of novel theory and methods to understand how genetic and non-genetic factors shape complex human traits, using interdisciplinary modeling and large-scale datasets. It is a research grant aimed primarily at universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. No award amounts are specified. Clinical trials are not allowed under this opportunity, and the eligibility list is research-institution oriented rather than open to nonprofits, small businesses, or individuals broadly.

National Institutes of Health · Up to $350K

This NIH/NCI R01 grant funds secondary analysis and integration of existing datasets to study cancer risk and related outcomes such as survival and treatment response. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. The award maximum is about $350,000. Eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly, and applicants typically need access to relevant existing data.

National Institutes of Health · Amount varies

This NIH/NHLBI R61/R33 supports investigator-initiated Phase I clinical trials for therapeutics or diagnostics for heart, lung, blood, and sleep disorders, with the first phase funding final pre-trial preparation. A clinical trial is required. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It is aimed at research teams with clinical-trial capacity. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R34 planning grant supports research on prevention and intervention strategies for fetal alcohol spectrum disorders across the lifespan, intended as a precursor to larger studies. Eligible applicants include universities, research institutions, and tribal and community organizations, and foreign organizations are listed among eligible applicants. It is aimed at research teams preparing for larger FASD studies. No specific award amount is stated.

National Institutes of Health · Amount varies

This NIH R21 funds development of novel theory and methods for understanding the genetic architecture of complex human traits, using interdisciplinary approaches, simulations, and existing large-scale datasets; no clinical trial is allowed. Eligible applicants include universities, research institutions, tribal and community organizations, and foreign organizations. It is aimed at research teams with methodological expertise. No specific award amount is stated.

National Institutes of Health · Up to $1.5M

This NIH/NHLBI R33 supports investigator-initiated Phase I clinical trials for therapeutics or diagnostics for heart, lung, blood, and sleep disorders; a clinical trial is required and applicants must be ready to start the trial early. Eligible applicants include universities, research institutions, and tribal and community organizations; foreign organizations are not eligible to apply, though non-U.S. components of U.S. organizations are. The maximum award is about $1.5 million. It requires clinical-trial readiness.

National Institutes of Health · Up to $250K

This NIH/National Library of Medicine R01 funds development of informatics and data science approaches that give individuals actionable insights into their own health; a clinical trial is optional. Eligible applicants include universities, research institutions, and tribal and community organizations, and foreign organizations are listed among eligible applicants. The maximum award is about $250,000. It requires informatics research capacity.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute R01 supports investigator-initiated clinical trials in cancer prevention and control, such as early detection, screening, and survivorship research. Typical applicants are universities, research institutions, hospitals, tribal organizations, and government and community organizations; foreign organizations are listed among eligible applicants here. A qualifying clinical trial is required, so it is geared toward established research teams. No specific award amount is stated.